Phase III Trial of Sirolimus in IBM

NCT04789070 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Inclusion Body Myositis

Interventions

DRUG: Sirolimus
DRUG: Placebo

Sponsor

University of Kansas Medical Center

Collaborators

[object Object]